This inventor holds 1 USPTO granted patent. Top assignee: National Institute of Health and Medical Research. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Genevieve Laflamme: Innovator in Antibody Research
Introduction
Genevieve Laflamme is a prominent inventor based in San Francisco, CA. She has made significant contributions to the field of immunology, particularly through her work on antibodies. Her innovative research has led to the development of a unique patent that addresses critical aspects of lymphocyte activation.
Latest Patents
Genevieve holds a patent for an Anti-CD28 antibody. This antibody or antibody fragment is specifically directed against the CD28 receptor, effectively blocking the interaction between B7-1 or B7-2 and CD28. The methods she developed for blocking activation via CD28 are crucial for understanding CD28-dependent lymphocyte activation.
Career Highlights
Genevieve is affiliated with the Institut National de la Santé et de la Recherche Médicale, where she continues her research and development efforts. Her work has garnered attention in the scientific community, showcasing her dedication to advancing medical research.
Collaborations
Genevieve has collaborated with notable colleagues, including Jean-Paul Soulillou and Bernard Vanhove. These partnerships have enriched her research and contributed to the advancement of her projects.
Conclusion
Genevieve Laflamme's innovative work in antibody research exemplifies her commitment to improving medical science. Her contributions, particularly in the area of lymphocyte activation, highlight the importance of her research in the field of immunology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile